Industry News
27 Feb
Global Chemical Regulations: REACH, TSCA & Emerging Compliance Trends 2026 Overview
The global landscape for chemical regulation is rapidly evolving as governments, industry groups, and civil society respond to heightened concerns over health, environment, and sustainability. Two of the most influential regulatory frameworks — the EU’s REACH and the U.S. Toxic Substances Control Act (TSCA) — remain at the center of this evolution, while emerging trends […]
27 Feb
Biobased & Renewable Chemicals: Market Growth and Patent Landscape
Biobased & Renewable Chemicals: Market Growth and Patent Landscape Executive summary The global shift from fossil feedstocks to biomass-derived molecules is moving from niche R&D to industrial scale. Driven by policy incentives, corporate sustainability targets, technology advances in fermentation and biocatalysis, and growing consumer demand for circular products, the biobased chemicals sector is entering […]
26 Feb
Freedom-to-Operate Risks Rise in CRISPR & Gene Therapy Patents
Navigating IP Minefields in the Next Wave of Genetic Medicine Introduction: Innovation Meets the Patent Wall CRISPR gene editing and advanced gene therapies are no longer futuristic concepts—they are rapidly becoming mainstream tools in modern medicine. From one-time curative therapies for rare genetic disorders to next-generation oncology treatments, the promise of genetic medicine is transforming […]
25 Feb
White Hydrogen Enters Pilot Phase: Technology Maturity & Policy Support in Focus
📌 Executive Summary (Intro) Expanding into global markets opens new growth opportunities—but it also exposes businesses to new infringement risks. A product that is safe to sell in one country may infringe patents, trademarks, or designs in another. Understanding how IP rights differ across jurisdictions is critical before entering international markets. 🔹 1. IP Rights […]
24 Feb
Japan Approves Next-Gen Antimicrobial to Combat Drug-Resistant Sepsis
📌 Executive Summary (Intro) Expanding into global markets opens new growth opportunities—but it also exposes businesses to new infringement risks. A product that is safe to sell in one country may infringe patents, trademarks, or designs in another. Understanding how IP rights differ across jurisdictions is critical before entering international markets. 🔹 1. IP Rights […]
23 Feb
Claim Drafting Strategies: How to Balance Scope and Enforceability
🔹 Introduction: Why Claim Drafting Is the Heart of Patent Value A patent’s real power lies in its claims, not just the invention description Overly broad claims risk rejection or invalidation Overly narrow claims limit commercial protection The goal: broad enough to deter competitors, precise enough to withstand examination and enforcement 🔹 1. Understanding Claim […]
19 Feb
Freedom to Operate (FTO) in Pharma: Why Skipping It Can Cost Millions
In pharma, innovation doesn’t fail only in the lab.Many promising products fail at launch because of patent roadblocks that could have been avoided early. This is where Freedom to Operate (FTO) becomes critical. What Is Freedom to Operate (FTO)? Freedom to Operate is a legal and strategic assessment to check whether your product, process, or […]
16 Feb
Service Robots vs Industrial Robots: Which Is Right for Your Business?
🔹 Introduction Robots are no longer limited to factory floors. From hospitals and hotels to warehouses and retail stores, businesses are adopting robots to improve efficiency, reduce costs, and enhance customer experience. However, choosing between service robots and industrial robots can be confusing. This blog breaks down the differences, use cases, benefits, and helps you […]
05 Feb
The Rise of Immune Engagers: Strategic Implications for Pharma R&D and Licensing
The landscape of oncology is undergoing a profound transformation driven by immunotherapy innovation. Over the past decade, immune checkpoint inhibitors, CAR-T therapies, and antibody-drug conjugates have reshaped cancer treatment paradigms. Yet, among these breakthroughs, T cell engagers and related immune engager platforms are emerging as one of the most strategically important innovations in oncology drug […]
04 Feb
Beyond Patents: How Universities Can Build Sustainable Revenue Models from IP Assets
Beyond Patents: How Universities Can Build Sustainable Revenue Models from IP Assets For decades, universities have been engines of innovation producing breakthrough research in life sciences, engineering, AI, clean energy, and advanced materials. Yet despite generating vast intellectual property (IP), many universities struggle to convert these assets into sustainable and scalable revenue streams. The […]